SpartanNash Company (SPTN): Price and Financial Metrics


SpartanNash Company (SPTN)

Today's Latest Price: $21.77 USD

0.15 (-0.68%)

Updated Jun 4 6:55pm

Add SPTN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 56 in Food Makers

See all "A" rated Strong Buy stocks

SPTN Stock Summary

  • SpartanNash Co's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 97.49% of US listed stocks.
  • SPTN's price/sales ratio is 0.09; that's higher than the P/S ratio of merely 4.04% of US stocks.
  • SpartanNash Co's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 28.31%, greater than the shareholder yield of 90.93% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to SpartanNash Co, a group of peers worth examining would be PFGC, COKE, TSRI, TECD, and SFM.
  • SPTN's SEC filings can be seen here. And to visit SpartanNash Co's official web site, go to www.spartannash.com.
SPTN Daily Price Range
SPTN 52-Week Price Range

SPTN Stock Price Chart More Charts


SPTN Price/Volume Stats

Current price $21.77 52-week high $22.80
Prev. close $21.92 52-week low $8.82
Day low $21.46 Volume 469,500
Day high $22.35 Avg. volume 466,463
50-day MA $16.78 Dividend yield 3.54%
200-day MA $13.75 Market Cap 776.78M

SpartanNash Company (SPTN) Company Bio


SpartanNash Company operates as a grocery distributor and retailer primarily in the United States. The company operates in three segments: Military, Food Distribution, and Retail. The company was founded in 1917 and is based in Grand Rapids, Michigan.

SPTN Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$21.77$121446%

Below please find a table outlining a discounted cash flow forecast for SPTN, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that SpartanNash Co ranked in the 80th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 449%. The most interesting components of our discounted cash flow analysis for SpartanNash Co ended up being:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 47. Its equity weight surpasses that of merely 17.08% of free cash flow generating stocks in the Consumer Defensive sector.
  • SpartanNash Co's weighted average cost of capital (WACC) is 10%; for context, that number is higher than 74.72% of tickers in our DCF set.
  • SpartanNash Co's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%436%
1%441%
2%446%
3%452%
4%457%
5%462%

For other companies in the Consumer Defensive that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as SPTN, try ALCO, BTI, BRFS, SANW, and SUMR.


SPTN Latest News Stream


Event/TimeNews Detail
Loading, please wait...

SPTN Latest Social Stream


Loading social stream, please wait...

View Full SPTN Social Stream

Latest SPTN News From Around the Web

Below are the latest news stories about SpartanNash Co that investors may wish to consider to help them evaluate SPTN as an investment opportunity.

Senate Gives More Flexibility to Small Businesses: 6 Winners

Small-cap stocks have been driving markets lately, with many predicting this to be the beginning of the end of their years-long bear market.

Yahoo | June 4, 2020

SpartanNash (SPTN) Q1 Earnings Surpass Estimates, Sales Up

SpartanNash's (SPTN) first-quarter fiscal 2020 sales improve year over year on the back of strong consumer demand due to the coronavirus pandemic.

Zacks Investment Research | May 28, 2020

Zacks.com featured highlights include: SpartanNash Company, BG Foods, QIAGEN, Regeneron Pharmaceuticals and United Therapeutics

Zacks.com featured highlights include: SpartanNash Company, BG Foods, QIAGEN, Regeneron Pharmaceuticals and United Therapeutics

Zacks Investment Research | May 28, 2020

Why SpartanNash Stock Rose This Morning Before Giving Back Gains

Shares of SpartanNash (NASDAQ: SPTN) rose this morning, with gains of as much as 11% before closing roughly flat for the day, after the company reported first-quarter earnings. The grocery wholesaler and retailer easily beat expectations as grocery demand remains strong amid the COVID-19 pandemic. SpartanNash estimates that $0.38 of adjusted earnings per share was driven by increased consumer demand related to the crisis as people stocked up on food and other consumer staples.

Yahoo | May 28, 2020

SpartanNash Company (SPTN) Q1 2020 Earnings Call Transcript

SPTN earnings call for the period ending April 18, 2020.

Yahoo | May 28, 2020

Read More 'SPTN' Stories Here

SPTN Price Returns

1-mo 35.81%
3-mo 81.30%
6-mo 55.60%
1-year 99.88%
3-year -15.96%
5-year -17.93%
YTD 55.32%
2019 -12.26%
2018 -33.27%
2017 -30.91%
2016 86.31%
2015 -15.54%

SPTN Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full SPTN Dividend History

Continue Researching SPTN

Here are a few links from around the web to help you further your research on SpartanNash Co's stock as an investment opportunity:

SpartanNash Co (SPTN) Stock Price | Nasdaq
SpartanNash Co (SPTN) Stock Quote, History and News - Yahoo Finance
SpartanNash Co (SPTN) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9641 seconds.